Please select a video from the list below.
Cases in PAH: Sarcoidosis
Dr. Roxana Sulica from Mt. Sinai in New York discusses highlights from her CHEST session on challenging cases, describing the subset of patients with sarcoidosis and PAH. Approximately 8-50% of patients with sarcoidosis will develop PAH. For these WHO Group 5 patients, there are no FDA approved therapies, however several treatments are being studied and may be included in future treatment guidelines. She emphasizes that degree of right ventricular failure is important in determining the appropriate treatment.
Recent Video
Most Viewed
Specialties :                    Search :
RESPITE Study Results
RESPITE Study Results Views - 919
ICU Management of PH
ICU Management of PH Views - 142